We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PROF market cap is 171.24M. The company's latest EPS is USD -0.9259 and P/E is -8.46.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.91M | 2.23M | 2.83M | 3.71M | 2.62M |
| Operating Income | -7.48M | -7.83M | -8.99M | -17.74M | -11.17M |
| Net Income | -6.2M | -6.92M | -9.36M | -5.33M | -10.72M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.3M | 6.87M | 6.68M | 7.2M | 10.68M |
| Operating Income | -18.86M | -30.29M | -32.13M | -28.65M | -33.06M |
| Net Income | -21.62M | -30.7M | -28.67M | -28.32M | -27.82M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 57.38M | 50.03M | 42.24M | 70.23M | 60.86M |
| Total Liabilities | 11.52M | 10.79M | 11.17M | 9.81M | 10.07M |
| Total Equity | 45.86M | 39.24M | 31.06M | 60.42M | 50.79M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 104.6M | 86.78M | 64.42M | 43.96M | 70.23M |
| Total Liabilities | 7.25M | 6.16M | 12.42M | 12.73M | 9.81M |
| Total Equity | 97.35M | 80.62M | 52M | 31.22M | 60.42M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.1M | -11.45M | -17.81M | -23.45M | -8.28M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 20.38M | 19.71M | 19.04M | 54.7M | -290k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.57M | -22.36M | -25.8M | -22.61M | -23.45M |
| Investing | -350k | -593k | N/A | N/A | N/A |
| Financing | 87.43M | 5.95M | 7.03M | 1.76M | 54.7M |
| Market Cap | 171.24M |
| Price to Earnings Ratio | -8.46 |
| Price to Sales Ratio | 22.03 |
| Price to Cash Ratio | 4.28 |
| Price to Book Ratio | 3.89 |
| Dividend Yield | - |
| Shares Outstanding | 30.04M |
| Average Volume (1 week) | 23.26k |
| Average Volume (1 Month) | 28.19k |
| 52 Week Change | -38.97% |
| 52 Week High | 11.42 |
| 52 Week Low | 3.895 |
| Spread (Intraday) | 4.29 (47.83%) |
| Company Name | Profound Medical Corporation |
| Address |
2400 skymark avenue, unit 6 mississauga, ontario L4W 5K5 |
| Website | https://www.profoundmedical.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
